Dr. Srinagesh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-6661Fax+1 650-498-6205
Education & Training
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2020 - 2023
Icahn School of Medicine at Mount SinaiClass of 2020
Certifications & Licensure
CA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Effects of an initial anti-CD19 CAR T-cell therapy on subsequent anti-CD22 CAR T-cell manufacturing and clinical outcomes in patients with r/r LBCL.Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton, Neha Agarwal, Hrishikesh K Srinagesh
Cancer Discovery. 2025-01-07 - 4 citationsA phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.Hrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz, Nikeshan Jeyakumar, Mark Hamilton
Blood. 2024-10-17 - 4 citationsCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.Matthew J Frank, John H Baird, Anne Marijn Kramer, Hrishikesh K Srinagesh, Shabnum Patel
Lancet. 2024-07-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
